V275 Adverse reactions: cultures, water review, corrective action
Written V0275 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
§ 494.40(d) - Adverse events. A dialysis facility must maintain active surveillance of patient reactions during and following dialysis. When clinically indicated (for example, after adverse patient reactions) the facility must—
(1) Obtain blood and dialysate cultures and endotoxin levels;
(2) Evaluate the water purification system; and
(3) Take corrective action.
CMS's interpretive guidance
Interpretive Guidance § 494.40(d)
Responsible staff (nurses and patient care technicians) must be familiar with symptoms which might indicate a patient is having a reaction related to water or dialysate and must be able to describe appropriate actions to take in the event a patient or group of patients experiences such symptoms.
Facility or patient medical records (as appropriate) must demonstrate that any adverse incidents (such as fever, chills, or infection) were identified by staff and that appropriate actions were taken.
The medical director must develop standard protocols that require the collection of blood and dialysate cultures and endotoxin levels in the event of a patient's adverse reaction(s) during or following dialysis treatment.
Responsible staff (i.e., the nurse manager, charge nurses, water treatment technicians, chief technician and medical director) must demonstrate recognition of the need to evaluate the water system in the event of patient adverse reaction(s) during or following dialysis treatment and to take the indicated corrective action.
https://middlemolecule.com/rulebook/tags/v275/